Care2care Choice Rx
Our PBM solution in short.
We offer a transparent, 100% Pass Through solution. Our model is a “Cost +” model,
Meaning Cost of the drug + a moderate admin fee. Our drug formulary design is founded in science, thanks to a partnership with an independent academic system. This eliminates conflict of interest, in particular for Specialty drugs guidance.
In 2019, C2CRx member companies spent 47% PMPM less than the Industry National Average; Since drugs represent 20 to 30% of a plans costs, this represents 10 to 12% global savings!
Manufacturer Assistance Programs
Our Map/Pap solution
Plan for Employees
Map and Pap
C2C Choice Rx provides patient concierge and advocacy services for possible eligibility to PAPs. With our patient assistance program, you will typically get your medication for free.
Our Rx mail-order program
Via a Mail Order Program we are providing drugs from brick and mortar pharmacies located in Canada, UK and other “Tier One” countries, as defined by Congress. All medications provided through our program are FDA approved, delivered in the originally sealed packaging from the manufacturer. Programs main features are:
1. FIRST STEP
A partnership with experienced pharmacists
Our program partners provide you a wide range of prescription maintenance medications.
2. SECOND STEP
A simple and transparent workflow
The patient has access to a secure, HIPAA compliant, user-friendly platform. The prescription is uploaded on the platform.
3. third step
A user-friendly secure patient portal
It is reviewed by licensed pharmacists and dispatched to the relevant MD. Patient assistance is available at every step through toll-free telephone, mail and fax.
4. fourth step
A safe delivery to the patient’s mailbox
Medications are then shipped to the personal address entered in the patient profile. The package includes up to a 90-day supply .
news and legislation
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
After wrapping up the 2023 enrollment, employers are now planning their next moves to mitigate the continuously growing healthcare costs impacting their plans. This is particularly true for pharmacy costs.
PhRMA, a Big Pharma lobbying group, released an advertising touting that drug prices were not fueling inflation. To prove it, they produce the graphic below.
Get In Touch
We are here to help you 7 days a week and respond within 24 hours.